Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitalsArticle Published on 2022-10-272022-11-16 Journal: BMC Infectious Diseases [Category] COVID19(2023년), SARS, 변종, [키워드] Acute respiratory infection adjusted adjusted odds ratio age analysed Analysis applied B.1.1.529 B.1.617.2 Characteristics characterized Cohort Comorbidity Course COVID-19 COVID-19 case COVID-19 patient defined Delta described difference disease severity dominant variant exceeded female Gender Germany Helio hospital In-hospital in-hospital mortality Infection infections Infectious disease Inpatient intensive care treatment mechanical ventilation omicron outcome outcomes pandemic Patient reduced Regression risk SARS-COV-2 infection SARS-CoV-2 variant SARS-CoV-2 variants significantly lower stratified Surveillance variant virus [DOI] 10.1186/s12879-022-07781-w PMC 바로가기
Comparative Analysis of Antibody Titers against the Spike Protein of SARS-CoV-2 Variants in Infected Patient Cohorts and Diverse Vaccination RegimesArticle Published on 2022-10-132022-11-15 Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] accompanied antibody Antibody Response AstraZeneca B cell benefit booster vaccination cells Comparative courses COVID-19 COVID-19 pandemic Critical critical COVID-19 patients exceeded follicular Frequency Infection Inflammation Inflammatory response Johnson & Johnson long-COVID Lymphocytes Mild Moderna mRNA vaccine neutralizing antibody patients patients who survived Pfizer-BioNTech recommendation reduced regime SARS-CoV-2 SARS-CoV-2 patient severe COVID-19 disease the SARS-CoV-2 virus the Spike titer understanding vaccination Vaccination strategy Vaccine [DOI] 10.3390/ijms232012231 PMC 바로가기
MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literatureArticle Published on 2022-10-012022-11-15 Journal: Journal of Neurology [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] acute respiratory syndrome Adults affected analysed antibody AstraZeneca attack available data AZD1222 blindness BNT162b2 booster vaccination Brain Brainstem Brainstem encephalitis Case report cerebrospinal fluid ChAdOx1 ChAdOx1 nCoV-19 ChAdOx1-S CNS complete recovery coronavirus Coronavirus disease 2019 Coronavirus disease 2019 (COVID-2019) COVID-19 CSF detectable disease dysfunction Encephalitis epidemiological Escalation exceeded female first dose functional glycoprotein IgG1 immunization Immunoglobulin Immunotherapy laboratory feature Longitudinally extensive transverse myelitis (LETM) majority male median median age median interval MOG MOG antibodies (MOG-IgG) mRNA vaccine mRNA-1273 much lower Myelin Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) Myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis (MOG-EM) Myelitis Neuromyelitis Optica Neuromyelitis optica spectrum disorders occur occurred Optic Optic neuritis Oxford paraplegia Patient patients patients with SARS-CoV-2 Pfizer phenotype plasma Postinfectious Postvaccinal predominant radiological remained required residual symptom SARS-CoV2 serum Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) severity steroid treatment therapy Treatment Treatment outcome vaccination Vaccine WCC white cell [DOI] 10.1007/s00415-022-11194-9 PMC 바로가기
Managing Hospital Capacity: Achievements and Lessons from the COVID-19 PandemicArticle Published on 2022-10-012022-11-16 Journal: Prehospital and Disaster Medicine [Category] 변종, [키워드] achievement Admission Admissions age Capacity Care caused coordination coronavirus disease COVID-19 COVID-19 patients Critical care exceeded Health Health care system help hospital hospital ward ICU ICU patient In-hospital Infectious disease intensive care lack lesson managing Netherlands pandemic Patient patient triage reduce reducing Region Regional service Surveillance transfer transferred Treatment Triage variant [DOI] 10.1017/S1049023X22001169 PMC 바로가기
New-Onset and Relapsed Membranous Nephropathy post SARS-CoV-2 and COVID-19 VaccinationArticle Published on 2022-09-282022-11-15 Journal: Viruses [Category] SARS, 진단, [키워드] aberrant immune response Acute kidney injury acute respiratory syndrome AKI antibody Clinical characteristics collected contribute Conventional coronavirus COVID-19 COVID-19 vaccination Cross immunity disease disease onset elevated exceeded FIVE immune response immunosuppressive drug Immunosuppressive medication induce kidney tissue mechanism Membranous nephropathy occurred outbreak Pathogenesis Patient patients phospholipase Phospholipase A2 positive Prognosis receptor remained reported SARS-CoV-2 SARS-COV-2 infection second dose serum subepithelial suffered Treatment vaccination Vaccine Viral antigen virus particle was measured [DOI] 10.3390/v14102143 PMC 바로가기
SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recoveryArticle Published on 2022-09-282022-11-15 Journal: Science Translational Medicine [Category] SARS, 진단, 치료기술, [키워드] acute respiratory syndrome affected animal model change coronavirus correlated COVID COVID-19 demonstrated detectable exceeded hamster highlight host response Human IAV individual Infection Infectious virus influenza A virus Injury interferon response kidney lack lung mechanism molecular mechanism olfactory Olfactory epithelium PASC pathology Perturbation Proinflammatory cytokine response Result SARS-CoV-2 SARS-COV-2 infection sustained T cell activation tissue transcriptional change unique viral clearance [DOI] 10.1126/scitranslmed.abq3059 PMC 바로가기
Older Adults Mount Less Durable Humoral Responses to Two Doses of COVID-19 mRNA Vaccine but Strong Initial Responses to a Third DoseArticle Published on 2022-09-212022-11-15 Journal: The Journal of Infectious Diseases [Category] SARS, 진단, [키워드] ACE2 ACE2 displacement acute respiratory syndrome Adults age antibody concentration benefit binding binding antibodies chronic health condition chronic health conditions circulating antibody comparable coronavirus coronavirus disease COVID-19 COVID-19 mRNA vaccines COVID-19 vaccine domain dose doses exceeded functional humoral Humoral immunity Humoral response humoral responses immune immunogenicity data less magnitude mount mRNA Older Older adults omicron reached response Result SARS-CoV-2 Spike protein strain Strong Vaccine vaccine dose vaccine doses viral neutralization Virus neutralization [DOI] 10.1093/infdis/jiac199 PMC 바로가기
Application of Statistical Learning to Identify Omicron Mutations in SARS-CoV-2 Viral Genome Sequence Data From Populations in Africa and the United StatesArticle Published on 2022-09-012022-11-15 Journal: JAMA Network Open [Category] SARS, 변종, 치료기술, [키워드] application applied assist averaged case sery collected detect detectable disease distribution effort evaluate exceeded Genome sequences genomic sequence help IMPROVE individual investigated learning Lineage OCP omicron outcome percentage Population SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 viral sequence South Africa statistical suggested Surveillance the United State The United States threshold variant viral sequences [DOI] 10.1001/jamanetworkopen.2022.30293 PMC 바로가기
Impact of the COVID-19 Pandemic on Fecal Immunochemical Testing, Colonoscopy Services, and Colorectal Neoplasia Detection in a Large United States Community-based PopulationResearch article Published on 2022-09-012022-10-05 Journal: Gastroenterology [Category] 진단, 치료기술, [키워드] affected age Cancer Care changes in Colonoscopy Colorectal Colorectal cancer COVID-19 COVID-19 pandemic declined detection diagnosed diagnostic exceeded fecal fit Health help immunochemical Impact increase in investigated National neoplasia pandemic Patient performed Population positive Positive test reached reduction in Result resulting retrospective cohort study Screening Testing United State Volume [DOI] 10.1053/j.gastro.2022.05.014 [Article Type] Research article
Evaluating the Performance of Centers for Disease Control and Prevention COVID-19 Community Levels as Leading Indicators of COVID-19 MortalityArticle Published on 2022-09-012022-11-16 Journal: Annals of internal medicine [Category] Fulltext, MERS, 변종, [키워드] Analysis CDC center Community complicate Control Council COVID-19 death diagnostic elevated evaluate Evaluating Evolution exceeded Hospital admission Hospital admissions hospitalizations Immunity IMPROVE Indicator interquartile range IQR leading Level lower mortality median medium Metrics Mortality mortality rate mortality risk National Negative predictive value outcome performance Positive predictive value Predictive predictor prevention public health Ratio reported risk sensitivity specificity state Support Surveillance threshold time Viral variants [DOI] 10.7326/M22-0803 PMC 바로가기